The Honest Edge

Ethical Leadership When No One Is Watching: Trust as the Ultimate Competitive Advantage

The sales representative is sitting across from a physician, introducing a newly approved medication. The data are solid. The unmet need is real. The physician is engaged, asking thoughtful questions, and clearly looking for solutions for patients who have limited options. As the conversation unfolds, the representative approaches a familiar crossroad. There is a clinically relevant limitation in the data — well documented, but inconvenient.
Bringing it forward will slow the conversation and raise doubts. Leaving it out will keep the momentum going and likely secure early adoption.

There is no supervisor in the room. No regulator listening in. The materials technically comply with approved messaging. The choice belongs entirely to the individual. Do they proactively disclose the limitation, trusting the physician to weigh the information fully? Or do they focus only on the positive, assuming the details can be addressed later if needed?

This moment — repeated thousands of times every day across the healthcare system — is where ethical leadership quietly reveals itself. It is not about policy or process, but about judgment and character. Over my career in the pharmaceutical industry, rising to senior commercial leadership roles in the United States and globally, I have learned that trust is the cornerstone of successful pharmaceutical commercialization. And that trust is built — or broken — one conversation at a time.

Trust Is the Currency of Pharmaceutical Leadership

Every business values trust, but in health care, trust is existential. Physicians prescribe medicines based on their belief that the data is accurate and complete. Regulators approve therapies based on confidence that companies are transparent and scientifically rigorous. Patients and caregivers make deeply personal decisions believing that the benefits and risks have been communicated honestly.

In commercial leadership, the temptation to selectively frame information is ever-present. Markets are competitive. Pipelines are fragile. Shareholders demand growth. But ethical leaders understand that credibility, once compromised, is almost impossible to regain. A short-term commercial win achieved through exaggeration, omission or ambiguity carries long-term costs that far outweigh the immediate gain.

I have seen firsthand that companies with the strongest reputations for integrity ultimately outperform — not because they are perfect, but because they are trusted. Physicians return calls. Regulators engage constructively. Employees speak up early when problems arise.

Ethical leadership builds a reservoir of goodwill that sustains organizations through inevitable setbacks.
 
Ethical Leadership Requires Courage, Not Just Compliance

Many organizations confuse ethics with compliance. As a commercial executive who has held senior roles in commercial compliance, I can speak with confidence that compliance is necessary but can be insufficient. Compliance tends to ask, “What are we allowed to do?” Ethical leadership is a step higher and asks, “What is the right thing to do?”

In pharmaceutical commercialization, leaders constantly navigate gray zones — how to communicate emerging data, how to position a product against competitors, how to set expectations internally and externally. These moments don’t always come with clear rules. They require judgment, courage and a willingness to choose integrity over convenience.

Ethical leaders create cultures where uncomfortable conversations are welcomed, not avoided. They invite challenge from medical, legal, regulatory and commercial teams — not as a formality, but as a strategic asset to get the best result. They reward transparency, even when it slows momentum. And they model behavior that signals to the organization that results achieved the wrong way are not results worth having.

Stakeholders Are Watching — Especially Your People

While much attention is paid to external stakeholders, ethical leadership matters just as much internally. Employees watch how leaders behave under pressure. They notice which voices are heard, which concerns are dismissed, and which values are upheld when trade-offs arise.

The people who work for us want to be proud of what they do. High-performing teams are not motivated solely by compensation or promotion; they are motivated by purpose and trust. When employees believe their leaders will do the right thing — even when it is hard — they bring their full energy, creativity and commitment to the work.

Ethical leadership creates psychological safety. It empowers teams to raise concerns early, challenge assumptions, and protect patients and the enterprise alike. In health care, that internal trust is not just a cultural asset — it is a risk-management imperative.

Ethical Leadership Is a Long-Term Strategy

Some believe ethical leadership is good, of course, but likely slows growth. In my view, it enables durable success. Trust accelerates decision-making, strengthens partnerships, and attracts talent. It lowers friction with regulators and enhances credibility with customers.

Ethical leadership also shapes legacy. Long after products lose exclusivity and markets evolve, leaders are remembered for how they conducted themselves and how they treated people. I have had the good fortune in my career to have seen firsthand executive leaders who put science before profits. In an industry devoted to improving lives, that legacy matters.

Return to that sales conversation — the physician, the new product, the choice about what to say and what to leave unsaid. The ethical question was never simply about a data point or a sales objective. It was about credibility. Physicians rely on our industry not just for innovation, but for honesty. Patients ultimately rely on those physicians to make decisions informed by complete and accurate information. And sales professionals rely on their leaders to set clear expectations about what matters most.

Ethical leadership shows up in how we equip, coach and reward our teams. When leaders emphasize short-term results at the expense of transparency, they create pressure to compromise. When they reinforce trust, integrity and patient-centered thinking, they empower individuals to do the right thing — even when it is difficult.

In the pharmaceutical industry, trust is not built through perfect outcomes, but through principled behavior. Leaders who insist on credibility in every interaction — especially when no one is watching — protect not only their organizations, but the integrity of the healthcare system itself. Ethical leadership, practiced consistently and visibly, ensures that success is earned the right way and sustained over time.

---

In the Lead magazine is a collaboration between the Buccino Leadership Institute and the Stillman School of Business’s Department of Management. This edition reaffirms Seton Hall’s commitment to fostering innovative, ethical and impactful leadership. Stay ahead of the curve — explore the Spring 2026 issue of In the Lead.

Categories: Business, Science and Technology